Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-016095
Filing Date
2014-03-03
Accepted
2014-03-03 19:34:44
Documents
1
Period of Report
2014-02-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3963
  Complete submission text file 0001209191-14-016095.txt   5315
Mailing Address 3 TIMES SQUARE, 12TH FLOOR NEW YORK NY 10036
Business Address
CHANEY PAUL G (Reporting) CIK: 0001277477 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36296 | Film No.: 14662228

Mailing Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142 617-871-9911
Eleven Biotherapeutics, Inc. (Issuer) CIK: 0001485003 (see all company filings)

EIN.: 252025616 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations